Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of
chronic iron overload from blood transfusions. A comparative phase 3 trial was conducted to …

Deferiprone has been suggested as an effective oral chelation therapy for thalassemia
major. To assess its clinical efficacy, we compared deferiprone with deferoxamine in a large …

OBJECTIVE: To investigate abnormal phase on susceptibility-weighted imaging (SWI)-filtered
phase images indicative of iron content, in subcortical deep-gray matter (SDGM) of …

BACKGROUND AND OBJECTIVES: During the last decade new approaches to the treatment
of pulmonary arterial hypertension (PH) have increased symptomatic relief and prolonged …

Aim. Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular phenomenon recently
described in multiple sclerosis (MS) that is characterized by stenoses affecting the main …

Background Several studies have reported hypoperfusion of the brain parenchyma in
multiple sclerosis (MS) patients. We hypothesized a possible relationship between abnormal …

To assess whether cocaine exposure in utero affected adrenocortical responsiveness in the
neonatal period, salivary cortisol levels were compared between noncocaine‐exposed (n = …

AIM: Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular condition characterized
by anomalies of primary veins outside the skull that restrict normal outflow of blood from …

The prognosis for thalassemia major has dramatically improved in the last two decades.
However, many transfusion-dependent patients continue to develop progressive accumulation …

In order to investigate possible contamination of saliva samples with formula or breast milk
obtained from young infants for cortisol assays, we measured cortisol concentrations in 3 …